Enhancement of dissolution profile by solid dispersion (kneading) technique

AAPS PharmSciTech

Volumn 7, Issue 3, 2006, Pages

  Modi, Aftab ^a   Tayade, Pralhad ^b  

^a BOMBAY COLLEGE OF PHARMACY   (India)

^b INSTITUTE OF CHEMICAL TECHNOLOGY   (India)

Author keywords

Dissolution enhancement; Fast dissolving tablets; Solid dispersion; Valdecoxib

Indexed keywords

DRUG CARRIER; POLYMER; POVIDONE; VALCOX; VALDECOXIB; VALUS; ISOXAZOLE DERIVATIVE; SULFONAMIDE;

AQUEOUS SOLUTION; ARTICLE; CONTROLLED STUDY; CRYSTAL STRUCTURE; DIFFERENTIAL SCANNING CALORIMETRY; DISPERSION; DRUG FORMULATION; DRUG SOLUBILITY; DRUG STRUCTURE; INFRARED SPECTROSCOPY; PHYSICAL CHEMISTRY; SOLID; TABLET FORMULATION; X RAY DIFFRACTION; CHEMISTRY; SOLUBILITY; TABLET;

CALORIMETRY, DIFFERENTIAL SCANNING; CHEMISTRY, PHARMACEUTICAL; ISOXAZOLES; POVIDONE; SOLUBILITY; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; SULFONAMIDES; TABLETS; X-RAY DIFFRACTION;

EID: 33748209143     PISSN: 15309932     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/pt070368     Document Type: Article

References (21)

1. Medical Economics Company. Physician's Desk Reference. 57th ed. Stamford, CT: Thomson Healthcare; 2003.
2. Chiou WL, Riegelman S. Pharmaceutical applications of solid dispersion systems. J Pharm Sci. 1971;60:1281-1302.
3. Babu GV, Kumar NR, Himasankar K, Seshasayana A, Murthy KV. Nimesulide-modified gum karaya solid mixtures: preparation, characterization and formulation development. Drug Dev Ind Pharm. 2003;29:855-864.
4. Rogers JA, Anderson AJ. Physical characteristics and dissolution profiles of ketoprofen-urea solid dispersions. Pharm Acta Helv. 1982;57:276-281.
5. El-Gazayerly ON. Characterization and evaluation of tenoxicam coprecipitates. Drug Dev Ind Pharm. 2000;26:925-930.
6. Vippagunta SR, Maul KA, Tallavajhala S, Grant DJW. Solid-state characterization of nifedipine solid dispersions. Int J Pharm. 2002; 236:111-123.
7. Murali Mohan Babu GV, Prasad CHDS, Ramana Murthy KV. Evaluation of modified gum karaya as carrier for the dissolution enhancement of poorly water soluble drug nimodipine. Int J Pharm. 2002;234:1-17.
8. Okonogi S, Yonemochi E, Oguchi T, Puttipipatkhachorn S, Yamamoto K. Enhanced dissolution of ursodeoxycholic acid from the solid dispersion. Drug Dev Ind Pharm. 1997;23:1115-1121.
9. Torrado S, Torrado S, Torrado JJ, Cadorniga R. Preparation, dissolution and characterization of albendazole solid dispersions. Int J Pharm. 1996;140:247-250.
10. Margarit MV, Rodrýguez IC, Cerezo A. Physical characteristics and dissolution kinetics of solid dispersions of ketoprofen and polyethylene glycol 6000. Int J Pharm. 1994;108:101-107.
11. Yagi N, Terashima Y, Kenmotsu H, Sekikawa H, Takada M. Dissolution behavior of probucol from solid dispersion systems of probucol-polyvinylpyrrolidone. Chem Pharm Bull (Tokyo). 1996; 44:241-244.
12. Kushida, I, Ichikawa M, Asakawa N. Improvement of dissolution and oral absorption of ER-34122, a poorly water soluble dual 5-lipoxygenase/ cyclooxygenase inhibitor with anti-inflammatory activity by preparing solid dispersion. J Pharm Sci. 2002;91:258-266.
13. Danjo K, Nakata T, Otsuka A. Preparation and dissolution behavior of ethenzamide solid dispersions using various sugars as dispersion carriers. Chem Pharm Bull (Tokyo). 1997;45:1840-1844.
14. Arias MJ, Ginés JM, Moyano, JR, Pérez-Martínez JI, Rabasco AM. Influence of preparation method of solid dispersions on dissolution rate: study of triammterene-D-mannitol. system. Int J Pharm. 1995;123:25-31.
15. Tros de Ilarduya MC, Martín C, Goñi MM, Martinez-Ohárriz MC. Solubilization and interaction of sulindac with polyvinylpyrrolidone K30 in the solid state and in aqueous solution. Drug Dev Ind Pharm. 1998;24:295-300.
16. Sheu MT, Yeh CM, Sokoloski TD. Characterization and dissolution of fenofibrate solid dispersion systems. Int J Pharm. 1994;103:137-146.
17. Yamashita K, Nakate T, Okimoto KA, et al. Establishment of new preparation method for solid dispersion formulation of tacrolimus. Int J Pharm. 2003;267:79-91.
18. Marin MT, Margarit MV, Salcedo GE. Characterization and solubility study of solid dispersions of flunarizine and polyvinylpyrrolidone. Farmaco. 2002;57:723-727.
19. Khan KA. The concept of dissolution efficiency. J Pharm Pharmacol. 1975;27:48-49.
20. Ford JL. The current status of solid dispersions. Pharm Acta Helv. 1986;61:69-88.
21. Mura P, Manderioli A, Bramanti G, Ceccarelli L. Properties of solid dispersions of naproxen in various polyethylene glycols. Drug Dev Ind Pharm. 1996;22:909-916.